Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
4.0
-23.73%
60%
—
-23.86%
40%
—
5 Years
Score4.0
Net Growth-23.73%
Net Trend60%
Net Income Consistency—
Rev Growth-23.86%
Rev Trend40%
Revenue Consistency—
C4 Therapeutics Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 33M to $ 35M and net income went from -$ 66M to -$ 104M. Revenue increased in 2 of those 5 years; net income in 3.
C4 Therapeutics Inc currently holds a 5-year HDB Score of 4.0 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 3.90 | — |
1 Year2025-08-12 | $ 2.24 | 74.11% |
5 Years2021-08-12 | $ 39.66 | -90.17% |
All Time2020-10-02 | $ 25.49 | -84.70% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2020-10-02 |
|---|---|---|---|---|
| Price | $ 3.90 | $ 2.24 | $ 39.66 | $ 25.49 |
| Return | — | 74.11% | -90.17% | -84.70% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 34M | -$ 103M | $ 235M |
| 2025 | $ 35M | -$ 104M | $ 248M |
| 2024 | $ 35M | -$ 105M | $ 244M |
| 2023 | $ 20M | -$ 132M | $ 253M |
| 2022 | $ 31M | -$ 128M | $ 276M |
| 2021 | $ 45M | -$ 83M | $ 309M |
| IPO2020 | $ 33M | -$ 66M | $ 371M |
Explore beyond CCCC
You're looking at C4 Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
